Baird Medical Sponsored and Participated in 2024 Guangdong Thyroid Surgery Committee Annual Meeting
Baird Medical (NASDAQ: BDMD) sponsored and participated in the 2024 Guangdong Thyroid Surgery Committee Annual Meeting in Guangdong, China. The two-day event, hosted by the Guangdong Provincial Hospital of Traditional Chinese Medicine, focused on advancing thyroid disease treatment. Baird Medical showcased its microwave ablation (MWA) technology and engaged with healthcare professionals to discuss innovations in endoscopic and minimally invasive surgery.
Chairwoman Haimei Wu emphasized the meeting's importance as a platform for sharing advancements in thyroid ablation and fostering collaboration among experts. The company utilized the interactive sessions to engage with specialists about current challenges and future directions in thyroid care, reinforcing its commitment to advancing minimally invasive surgery solutions globally.
Baird Medical (NASDAQ: BDMD) ha sponsorizzato e partecipato al Meeting Annuale del Comitato di Chirurgia della Tiroide del Guangdong 2024, tenutosi a Guangdong, Cina. L'evento di due giorni, ospitato dall'Ospedale Provinciale di Medicina Tradizionale Cinese del Guangdong, si è concentrato sul progresso nel trattamento delle malattie tiroidee. Baird Medical ha presentato la propria tecnologia di ablazione a microonde (MWA) e ha interagito con i professionisti del settore sanitario per discutere delle innovazioni nella chirurgia endoscopica e minimally invasive.
La presidente Haimei Wu ha sottolineato l'importanza dell'incontro come piattaforma per condividere i progressi nell'ablazione della tiroide e per promuovere la collaborazione tra esperti. L'azienda ha utilizzato le sessioni interattive per interagire con gli specialisti riguardo le sfide attuali e le direzioni future nella cura della tiroide, rafforzando il suo impegno per l'avanzamento delle soluzioni chirurgiche minimally invasive a livello globale.
Baird Medical (NASDAQ: BDMD) patrocinó y participó en la Reunión Anual del Comité de Cirugía de Tiroides de Guangdong 2024, que tuvo lugar en Guangdong, China. El evento de dos días, organizado por el Hospital Provincial de Medicina Tradicional China de Guangdong, se centró en avanzar en el tratamiento de enfermedades tiroIdeas. Baird Medical presentó su tecnología de ablación por microondas (MWA) y se relacionó con profesionales de la salud para discutir innovaciones en cirugía endoscópica y mínimamente invasiva.
La presidenta Haimei Wu enfatizó la importancia de la reunión como una plataforma para compartir avances en la ablación tiroidea y fomentar la colaboración entre expertos. La empresa utilizó las sesiones interactivas para dialogar con especialistas sobre los desafíos actuales y las direcciones futuras en el cuidado de la tiroides, reforzando su compromiso con el avance de las soluciones de cirugía mínimamente invasiva a nivel global.
베어드 메디컬 (NASDAQ: BDMD)는 중국 광둥에서 열리는 2024 광둥 갑상선 수술 위원회 연례 회의에 후원하고 참여했습니다. 두 날에 걸쳐 개최된 이번 행사에서는 광둥성 한방병원이 주최하며 갑상선 질환 치료의 발전에 초점을 맞췄습니다. 베어드 메디컬은 마이크로웨이브 절제 기술(MWA)을 선보였으며, 의료 전문가들과의 대화를 통해 내시경 및 최소 침습 수술 분야의 혁신에 대해 논의했습니다.
회장인 하이메이 우는 이번 회의가 갑상선 절제술의 발전을 공유하고 전문가들 간의 협력을 증진하는 플랫폼으로서의 중요성을 강조했습니다. 회사는 인터랙티브 세션을 활용하여 전문의들과 갑상선 치료의 현재 도전 과제 및 미래 방향에 대해 논의하며, 전 세계적으로 최소 침습 수술 솔루션을 발전시키겠다는 의지를 강화했습니다.
Baird Medical (NASDAQ: BDMD) a sponsorisé et participé à la Réunion Annuelle du Comité de Chirurgie de la Thyroïde de Guangdong 2024, qui s'est tenue à Guangdong, en Chine. Cet événement de deux jours, organisé par l'Hôpital Provincial de Médecine Traditionnelle Chinoise de Guangdong, s'est concentré sur l'avancement du traitement des maladies de la thyroïde. Baird Medical a présenté sa technologie d'ablation par micro-ondes (MWA) et a échangé avec des professionnels de la santé pour discuter des innovations en chirurgie endoscopique et minimalement invasive.
La présidente Haimei Wu a souligné l'importance de cette réunion comme plateforme de partage des avancées en matière d'ablation de la thyroïde et de promotion de la collaboration entre experts. L'entreprise a profité des sessions interactives pour dialoguer avec les spécialistes sur les défis actuels et les orientations futures dans le domaine des soins de la thyroïde, renforçant ainsi son engagement envers l'avancement des solutions de chirurgie minimalement invasive à l'échelle mondiale.
Baird Medical (NASDAQ: BDMD) hat das 2024 Guangdong Thyroid Surgery Committee Annual Meeting in Guangdong, China, gesponsert und daran teilgenommen. Die zweitägige Veranstaltung, die vom Guangdong Provincial Hospital of Traditional Chinese Medicine ausgerichtet wurde, konzentrierte sich auf die Fortschritte in der Behandlung von Schilddrüsenerkrankungen. Baird Medical präsentierte seine Mikrowellenablationstechnologie (MWA) und trat mit Fachleuten des Gesundheitswesens in Kontakt, um über Innovationen in der endoskopischen und minimalinvasiven Chirurgie zu diskutieren.
Die Vorsitzende Haimei Wu betonte die Bedeutung des Treffens als Plattform für den Austausch von Fortschritten in der Schilddrüsenablation und die Förderung der Zusammenarbeit unter Experten. Das Unternehmen nutzte die interaktiven Sitzungen, um mit Spezialisten über aktuelle Herausforderungen und zukünftige Richtungen in der Schilddrüsenversorgung zu sprechen und sein Engagement für die Weiterentwicklung minimalinvasiver Chirurgielösungen weltweit zu unterstreichen.
- None.
- None.
Throughout the two-day event, Baird Medical showcased its latest advancements in thyroid treatment, particularly focusing on its microwave ablation (MWA) technology. The forum brought together leading experts and healthcare professionals to discuss innovations in endoscopic and minimally invasive surgery, fostering the exchange of ideas and best practices.
"The Guangdong Thyroid Surgery Committee Annual Meeting is an ideal platform for sharing our latest advancements in thyroid ablation," said Haimei Wu, Chairwoman of Baird Medical. "This forum unites leading experts in thyroid surgery and provides valuable opportunities for collaboration and knowledge-sharing. We remain committed to refining surgical approaches and elevating patient care standards globally."
The event's interactive sessions provided Baird Medical with opportunities to engage in meaningful discussions with specialists about current challenges and future directions in thyroid care. Through its sponsorship and active participation, Baird Medical reinforced its commitment to driving progress in minimally invasive surgery and delivering impactful healthcare solutions worldwide.
By participating in this significant event, Baird Medical continues to solidify its role as an innovator in thyroid treatments, aiming to expand access to minimally invasive solutions and improve patient outcomes globally.
About Baird Medical
Baird Medical is a leading provider of minimally invasive microwave ablation (MWA) technology, offering advanced treatment solutions for conditions such as thyroid nodules, breast disease, uterine fibroids, and liver cancer. A publicly traded company on NASDAQ, Baird Medical is dedicated to enhancing patient care through precision, efficiency, and safety in its innovative medical devices. For more information, please visit https://bairdmed.com/
View original content to download multimedia:https://www.prnewswire.com/news-releases/baird-medical-sponsored-and-participated-in-2024-guangdong-thyroid-surgery-committee-annual-meeting-302333366.html
SOURCE BDMD
FAQ
What technologies did Baird Medical (BDMD) showcase at the 2024 Guangdong Thyroid Surgery Committee Meeting?
Where was the 2024 Baird Medical (BDMD) thyroid surgery meeting held?
What was the main focus of BDMD's participation in the 2024 Guangdong Thyroid Surgery Meeting?
How long was the 2024 Guangdong Thyroid Surgery Committee Meeting that BDMD sponsored?
